By: Benzinga
UPDATE: Morgan Stanley Downgrades Varian Medical Systems to Underweight on Accelerating Headwinds
In a report published Monday, Morgan Stanley analyst Steve Beuchaw downgraded the rating on Varian Medical Systems (NYSE: VAR ) from Equal-Weight to Underweight, but reiterated the $65.00 price target. In the report, Beuchaw noted, “Our analysis suggests accelerated Oncology software purchases tied to HITECH/HCIT incentives in 2012 offset deceleration
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here